1-3 of 3
Rieko Sekine, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Kenshi Suzuki, MD, PhD, Yu Abe, Kanji Miyazaki, Rieko Sekine, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yutaka Hattori, MD, PhD, Airi Hamano, Sumito Shingaki
Journal: Blood
Blood (2013) 122 (21): 3225.
https://doi.org/10.1182/blood.V122.21.3225.3225
Published: 2013
Journal Articles

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Kensuke Usuki, MD, PhD, Nozomi Yusa, Akira Hangaishi, MD, PhD, Rieko Sekine, MD, PhD, Kenshi Suzuki, MD, PhD, Shinya Kimura, MD, PhD, Arinobu Tojo, MD, PhD.
Journal: Blood
Blood (2012) 120 (21): 1684.
https://doi.org/10.1182/blood.V120.21.1684.1684
Published: 2012
Journal Articles

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Kenshi Suzuki, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yu Abe, MD, Rieko Sekine, MD, PhD, Yasunori Nakagawa, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1866.
https://doi.org/10.1182/blood.V120.21.1866.1866
Published: 2012